Skip to content

Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery

Impact of Intraperitonael Nebulization of Local Anesthetic on Postoperative Pain Associated With Laparoscopic Surgery

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01512914
Enrollment
120
Registered
2012-01-19
Start date
2008-05-31
Completion date
2009-09-30
Last updated
2012-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Laparoscopic Surgery

Keywords

Gynecologic laparoscopic surgery, Postoperative pain, Nebulization, Ropivacaine

Brief summary

Studies evaluating intraperitoneal local anesthetic instillation for pain relief after laparoscopic procedures have provided conflicting results. This randomized, double-blind study was designed to assess the effects of a novel intraperitoneal local anesthetic administration technique using nebulization on pain relief after gynecologic laparoscopic surgery.

Detailed description

Studies evaluating intraperitoneal local anesthetic (LA) instillation for pain relief after laparoscopic surgery have provided conflicting results. One of the factors that might contribute to failure of the instillation technique may be related to inadequate distribution of local anesthetic throughout the peritoneal surface. In contrast, nebulization should provide a uniform spread of drugs throughout the peritoneal cavity and thus may be beneficial to improve pain relief after laparoscopic procedures. The investigators reported that a microvibration-based nebulization device (Aeroneb Pro® system, Aerogen, Galway, Ireland) could be used for ropivacaine delivery into the insufflation gas required to create pneumorpeitoneum. The investigators hypothesized that intraperitoneal ropivacaine nebulization would provide superior pain relief than ropivacaine instillation after gynecologic laparoscopic surgery. This randomized, double blind, controlled clinical trial was designed to assess the analgesic efficacy of ropivacaine nebulization before or after surgery compared with intraperitoneal ropivacaine instillation and placebo after gynecologic laparoscopic procedures.

Interventions

preoperative instillation of saline 20 ml, nebulization of ropivacaine 1% 3 ml (30 mg) before surgery and nebulization of saline 3 ml after surgery

preoperative instillation of ropivacaine 0,5% 20 ml (100 mg) and nebulization of saline 3 ml before and after surgery

DRUGsaline

preoperative instillation of saline 20 ml and nebulization of saline before and after surgery

Sponsors

San Gerardo Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Females 18-70 years old, ASA score 1 - 3; * scheduled for laparoscopic operative surgery in the Obstetrics and Gynecology unit; * free from pain in preoperative period, without habitual analgesic use; * without cognitive impairment or mental retardation, who gave a written informed consent

Exclusion criteria

* Females under 18 or over 70; * ASA 4 or 5; * emergency/urgency criteria, postoperative admission in a intensive care unit with sedation or ventilatory assistance; cognitive impairment or mental retardation; * habitual analgesic use; progressive degenerative diseases of the CNS; * convulsions or chronic therapy with antiepileptic drugs; * severe hepatic or renal impairment; * pregnancy or lactation; * allergy to one of the specific substances used in the study; * acute infectious disease or inflammatory chronic disease, alcohol or drug addiction; * any kind of communication problem; * neurologic or psychiatric disease; * no written informed consent

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain24 hoursPostoperative pain was assessed by NRS (0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS). The proportion of patients with adequate pain control after surgery (dynamic NRS \< 3) will also be assessed.

Secondary

MeasureTime frameDescription
morphine consumption24 hoursThe total dose of morphine at every evaluation after awakening will be quantified using the PACU clinical chart and/or PCA infusers memory display
Unassisted walking time24 hoursUnassisted walking time is defined as the time in hours between PACU discharge and when the patient is able to walk out of his room and back to bed without any assistance.
Hospital staybetween surgery and dischargeWe define hospital stay as the elapsed time between surgery and hospital discharge
hospital morbidityup to dischargeAll complications or adverse effects associated or possibly associated with the interventions under study, surgery or anesthesia will be quantified using the anesthesia charts, surgical charts, surgical database.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026